Oramed to Present at Ladenburg Thalmann 2019 Healthcare Conference
NEW YORK, Sept. 18, 2019 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced that the company’s Chief Executive Officer, Nadav Kidron, will present and participate in one-on-one meetings at the 2019 Ladenburg Thalmann Healthcare Conference to be held […]
